Dermatology - European Medical Journal

This site is intended for healthcare professionals

Continue

Dermatology

Filter
10 Jul 2018

Ozenoxacin as a Novel Treatment Option for Impetigo

Ozenoxacin has been shown to be a well-tolerated and effective treatment for impetigo patients ≥2 months old, according to results of a randomised…
10 Jul 2018

Tralokinumab: A Safe and Effective Atopic Dermatitis Treatment

Tralokinumab is a fully human monoclonal antibody that has been shown to improve atopic dermatitis (AD) symptoms in patients with moderate-to-severe AD…
13 Jun 2018

Janssen’s Tremfya®▼ (guselkumab) receives its first two positive Health Technology Assessments in Europe

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the United Kingdom’s National Institute for Health and Care Excellence…
16 May 2018

Leprosy charity urges the British public not to be alarmed by red squirrel stories

Specialist leprosy charity, Lepra, states it is highly unlikely for people to catch leprosy from red squirrels, in response to research which has hit…
4 May 2018

Recommendation Given for New Psoriasis Treatment

Guselkumab (Tremfya®, Janssen, Beerse, Belgium) has been recommended for the treatment of adults with moderate-to-severe plaque psoriasis by the UK’s…
9 Apr 2018

Skin Bacteria Can Protect Against Cancer

Skin bacteria could provide protection from several types of cancer, according to the results of a new study carried out at the University of California…
9 Apr 2018

Approval of Interleukin-23 Antagonist for the Treatment of Plaque Psoriasis

Psoriasis treatment could be revolutionised following the recent approval of an interleukin-23 antagonist, known as tildrakizumab, by the U.S. Food and…
8 Mar 2018

Charity Finds 30% More Women Living with Undiagnosed Leprosy

Ahead of International Women’s Day, 8th March, UK-based leprosy charity, Lepra has published new research which found 30% more women living with leprosy…
We’ve noticed you’re accessing
from North/South America.